Unity Biotechnology

Creating therapeutics that prevent, halt, or reverse numerous diseases of aging.

Launch date

2009

Employees

Market cap

Net debt

-

Enterprise valuation

$11m (Public information from May 2024)

South San Francisco California (HQ)

http://unitybiotechnology.com/

https://twitter.com/unitybiotech https://www.facebook.com/fidelityinvestments https://www.linkedin.com/company/unity-biotechnology/

View job openings

Revenues, earnings & profits over time

USD	2020	2021	2022	2023	2024	2025	2026
Revenues	0000	0000	0000	0000	0000	0000	0000
% growth	-	-	(95 %)	-	-	-	53 %
EBITDA	0000	0000	0000	0000	0000	0000	0000
% EBITDA margin	-	(1203 %)	(23885 %)	-	-	(624 %)	-
Profit	0000	0000	0000	0000	0000	0000	0000
% profit margin	-	(1269 %)	(25393 %)	-	-	(404 %)	(203 %)
EV / revenue	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
EV / EBITDA	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x	00.0x
R&D budget	0000	0000	0000	0000	0000	0000	0000
R&D % of revenue	-	803 %	15618 %	-	-	-	-

Source: Dealroom estimates

Get premium to view all results

Date	Investors	Amount	Round
-	investor investor investor	$0.0	round
May 2009	N/A	$0.0	round
Jul 2013	N/A	$0.0	round
Jan 2015	investor investor investor	$0.0	round
Oct 2016	investor investor investor investor investor investor	$0.0	round
Aug 2017	investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor	$0.0	round
Mar 2018*	Venrock Founders Fund Fidelity Investments Baillie Gifford Invus ARCH Venture Partners Longevity Fund Altitude Life Science Ventures Pivotal Alpha Limited PFM Health Sciences 6 Dimensions Capital	$55.0m	Series C
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.